Understanding the value of meningococcal vaccination for adolescents and young adults in the United States: insights from a steady-state modelling approach
Abstract Background A two-dose series of quadrivalent meningococcal conjugate vaccine (MenACWY) is recommended for the prevention of invasive meningococcal disease (IMD) in adolescents in the United States. In June 2024, the Advisory Committee on Immunization Practices discussed plans to review the...
Saved in:
| Main Authors: | E. Langevin, C. Robertson, K. Galarza, A. Dogu, O. Cristeau, E. Clay, J. Wu, T. Shin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Public Health |
| Online Access: | https://doi.org/10.1186/s12889-025-21953-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Economic Evaluation of Adolescent Vaccination with Serogroup ACWY and C Meningococcal Vaccines in Germany
by: Sebastian Gruhn, et al.
Published: (2025-03-01) -
Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination
by: Jessica Presa, et al.
Published: (2025-06-01) -
Long-Term Impacts of Invasive Meningococcal Disease on Survivors and Their Caregivers in the United States and Canada
by: Todd Wolynn, et al.
Published: (2025-07-01) -
Meningococcal disease. Polysaccharide meningococcal vaccines. The historical aspects and the current state of vaccine development. Report 2
by: M. V. Abramtseva, et al.
Published: (2018-02-01) -
Enhanced Surveillance for Meningococcal Disease-United States, 2015-2019.
by: Amy B Rubis, et al.
Published: (2025-01-01)